Antiobesity efficacy of GLP-1 receptor agonist liraglutide is associated with peripheral tissue-specific modulation of lipid metabolic regulators
出版年份 2016 全文链接
标题
Antiobesity efficacy of GLP-1 receptor agonist liraglutide is associated with peripheral tissue-specific modulation of lipid metabolic regulators
作者
关键词
-
出版物
BIOFACTORS
Volume 42, Issue 6, Pages 600-611
出版商
Wiley
发表日期
2016-12-21
DOI
10.1002/biof.1295
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Altered expression of uncoupling protein 2 in GLP-1-producing cells after chronic high glucose exposure: implications for the pathogenesis of diabetes mellitus
- (2016) Francesca Urbano et al. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY
- Acute but not chronic activation of brain glucagon-like peptide-1 receptors enhances glucose-stimulated insulin secretion in mice
- (2015) E. Tudurí et al. DIABETES OBESITY & METABOLISM
- Expression of UCP2 in Wistar rats varies according to age and the severity of obesity
- (2015) Carmen Pheiffer et al. JOURNAL OF PHYSIOLOGY AND BIOCHEMISTRY
- Hypothalamic GLP-1: the control of BAT thermogenesis and browning of white fat
- (2015) Miguel López et al. Adipocyte
- GLP-1 Agonism Stimulates Brown Adipose Tissue Thermogenesis and Browning Through Hypothalamic AMPK
- (2014) D. Beiroa et al. DIABETES
- GLP-1 Receptor Localization in Monkey and Human Tissue: Novel Distribution Revealed With Extensively Validated Monoclonal Antibody
- (2014) Charles Pyke et al. ENDOCRINOLOGY
- Neuronal GLP1R mediates liraglutide’s anorectic but not glucose-lowering effect
- (2014) Stephanie Sisley et al. JOURNAL OF CLINICAL INVESTIGATION
- Differences in acute anorectic effects of long-acting GLP-1 receptor agonists in rats
- (2014) Stephanie Sisley et al. PEPTIDES
- CB1 Blockade Potentiates Down-Regulation of Lipogenic Gene Expression in Perirenal Adipose Tissue in High Carbohydrate Diet-Induced Obesity
- (2014) Margarita Vida et al. PLoS One
- Exenatide improves hepatic steatosis by enhancing lipid use in adipose tissue in nondiabetic rats
- (2014) Kosuke Tanaka WORLD JOURNAL OF GASTROENTEROLOGY
- GLP-1 receptor agonism ameliorates hepatic VLDL overproduction and de novo lipogenesis in insulin resistance
- (2014) Jennifer Taher et al. Molecular Metabolism
- Sugar, Uric Acid, and the Etiology of Diabetes and Obesity
- (2013) R. J. Johnson et al. DIABETES
- Oleoylethanolamide enhances -adrenergic-mediated thermogenesis and white-to-brown adipocyte phenotype in epididymal white adipose tissue in rat
- (2013) J. Suarez et al. Disease Models & Mechanisms
- The Role of Gastrointestinal Hormones in Hepatic Lipid Metabolism
- (2013) Jamie Mells et al. SEMINARS IN LIVER DISEASE
- Direct Control of Brown Adipose Tissue Thermogenesis by Central Nervous System Glucagon-Like Peptide-1 Receptor Signaling
- (2012) S. H. Lockie et al. DIABETES
- GLP-1 Receptor Activation Indirectly Reduces Hepatic Lipid Accumulation But Does Not Attenuate Development of Atherosclerosis in Diabetic MaleApoE−/−Mice
- (2012) Naim Panjwani et al. ENDOCRINOLOGY
- Multiple functions of microsomal triglyceride transfer protein
- (2012) M Mahmood Hussain et al. Nutrition & Metabolism
- Resveratrol up-regulates hepatic uncoupling protein 2 and prevents development of nonalcoholic fatty liver disease in rats fed a high-fat diet
- (2012) Morten Møller Poulsen et al. NUTRITION RESEARCH
- GLP-1 Receptor Activation Inhibits VLDL Production and Reverses Hepatic Steatosis by Decreasing Hepatic Lipogenesis in High-Fat-Fed APOE*3-Leiden Mice
- (2012) Edwin T. Parlevliet et al. PLoS One
- Glp-1 analog, liraglutide, ameliorates hepatic steatosis and cardiac hypertrophy in C57BL/6J mice fed a Western diet
- (2011) Jamie E. Mells et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- Reduction of body weight, liver steatosis and expression of stearoyl-CoA desaturase 1 by the isoflavone daidzein in diet-induced obesity
- (2011) A Crespillo et al. BRITISH JOURNAL OF PHARMACOLOGY
- Anti-obesity efficacy of LH-21, a cannabinoid CB1 receptor antagonist with poor brain penetration, in diet-induced obese rats
- (2011) Mónica Alonso et al. BRITISH JOURNAL OF PHARMACOLOGY
- Study of the Potential Association of Adipose Tissue GLP-1 Receptor with Obesity and Insulin Resistance
- (2011) Joan Vendrell et al. ENDOCRINOLOGY
- Uncoupling proteins and the control of mitochondrial reactive oxygen species production
- (2011) Ryan J. Mailloux et al. FREE RADICAL BIOLOGY AND MEDICINE
- Glucagon like-peptide 1 receptor and the liver
- (2011) Jens Pedersen et al. LIVER INTERNATIONAL
- Comparative Effects of the Long-Acting GLP-1 Receptor Ligands, Liraglutide and Exendin-4, on Food Intake and Body Weight Suppression in Rats
- (2011) Matthew R. Hayes et al. Obesity
- GLP-1 Analogs Reduce Hepatocyte Steatosis and Improve Survival by Enhancing the Unfolded Protein Response and Promoting Macroautophagy
- (2011) Shvetank Sharma et al. PLoS One
- Glucagon-like peptide-1 receptor is present on human hepatocytes and has a direct role in decreasing hepatic steatosis in vitro by modulating elements of the insulin signaling pathway
- (2010) Nitika Arora Gupta et al. HEPATOLOGY
- Long-term characterization of the diet-induced obese and diet-resistant rat model: a polygenetic rat model mimicking the human obesity syndrome
- (2010) Andreas Nygaard Madsen et al. JOURNAL OF ENDOCRINOLOGY
- Glucagon-like peptide-1 reduces hepatic lipogenesis via activation of AMP-activated protein kinase
- (2010) Shani Ben-Shlomo et al. JOURNAL OF HEPATOLOGY
- Liraglutide for weight loss in obese people
- (2010) Thomas Thum et al. LANCET
- Exenatide and weight loss
- (2010) David P. Bradley et al. NUTRITION
- Role of the glucagon-like-peptide-1 receptor in the control of energy balance
- (2010) Matthew R. Hayes et al. PHYSIOLOGY & BEHAVIOR
- The Role of Lipid Metabolism in the Pathogenesis of Alcoholic and Nonalcoholic Hepatic Steatosis
- (2010) Margaret Sozio et al. SEMINARS IN LIVER DISEASE
- Liraglutide, a once-daily human GLP-1 analogue, added to a sulphonylurea over 26 weeks produces greater improvements in glycaemic and weight control compared with adding rosiglitazone or placebo in subjects with Type 2 diabetes (LEAD-1 SU)
- (2009) M. Marre et al. DIABETIC MEDICINE
- Direct Control of Peripheral Lipid Deposition by CNS GLP-1 Receptor Signaling Is Mediated by the Sympathetic Nervous System and Blunted in Diet-Induced Obesity
- (2009) R. Nogueiras et al. JOURNAL OF NEUROSCIENCE
- Effects of liraglutide in the treatment of obesity: a randomised, double-blind, placebo-controlled study
- (2009) Arne Astrup et al. LANCET
- Blocking VLDL secretion causes hepatic steatosis but does not affect peripheral lipid stores or insulin sensitivity in mice
- (2008) Kaori Minehira et al. JOURNAL OF LIPID RESEARCH
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started